Arsenite induces delayed mutagenesis and transformation in human osteosarcoma cells at extremely low concentrations
Arsenite induces delayed mutagenesis and transformation in human osteosarcoma cells at extremely low concentrations
复制标题
DOI:
10.1002/em.10164
复制
发表时间:
2003-01-01
影响因子:
2.8
通讯作者:
Rossman, TG
中科院分区:
文献类型:
--
作者:
Mure, K;Uddin, AN;Rossman, TG
Arsenite is a human multisite carcinogen, but its mechanism of action is not known. We recently found that extremely low concentrations (less than or equal to0.1 muM) of arsenite transform human osteosarcoma TE85 (HOS) cells to anchorage-independence. In contrast to other carcinogens which transform these cells within days of exposure, almost 8 weeks of arsenite exposure are required for transformation. We decided to reexamine the question of arsenite mutagenicity using chronic exposure in a spontaneous mutagenesis assay we previously developed. Arsenite was able to cause a delayed increase in mutagenesis at extremely low concentrations (less than or equal to0.1 muM) in a dose-dependent manner. The increase in mutant frequency occurred after almost 20 generations of growth in arsenite. Transformation required more than 30 generations of continuous exposure. We also found that arsenite induced gene amplification of the dihydrofolate reductase (DHFR) gene in a dose-dependent manner. Since HOS cells are able to methylate arsenite at a very low rate, it was possible that active metabolites such as monomethylarsonous acid (MMA(III)) contributed to the delayed mutagenesis and transformation in these cells. However, when the assay was repeated with MMA(III), we found no significant increase in mutagenesis or transformation, suggesting that arsenite-induced delayed mutagenesis and transformation are not caused by arsenite's metabolites, but by arsenite itself. Our results suggest that long-term exposure to low concentrations of arsenite may affect signaling pathways that result in a progressive genomic instability. (C) 2003 Wiley-Liss, Inc.